🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ramya Thota

Intermountain Healthcare

ORCID: 0000-0001-6538-9924
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma”.

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.02.005
N/A
0.868DataRank · unranked
326 citations

S.L. Chan, R.K. Kelley, G. Lau, M. Kudo, W. Sukeepaisarnjaroen +198 more

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes

Cancers(2021)10.3390/cancers13215394
N/A
0.477DataRank · unranked
23 citations

Mingli Yang, Lance Pflieger, Michael J. Schell, Malini Rajan, Thomas B. Davis +5 more

Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

Research Square(2021)10.21203/rs.3.rs-224809/v1
N/A
0DataRank · unranked
0 citations

Kajsa E. Affolter, Angela K. Snow, Karen Curtin, Austin R. Cannon, Lisa Cannon‐Albright +3 more

APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4094
N/A
0DataRank · unranked
1 citations

Mingli Yang, Thomas Davis, Michael J. Schell, W. J. Pledger, Timothy J. Yeatman +1 more

Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer

Cancers(2022)10.3390/cancers14061451
N/A
0DataRank · unranked
4 citations

Shilpa Gupta, Mingli Yang, Lance Pflieger, Malini Rajan, Heiman Wang +4 more

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement

Journal of Clinical Oncology(2024)10.1200/jco.24.00961
N/A
0DataRank · unranked
15 citations

Patricia A. Hurley, Therica M. Miller, Suanna S. Bruinooge, Craig Lipset, R. Donald Harvey +9 more

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

BMC Cancer(2022)10.1186/s12885-022-09344-3
N/A
0DataRank · unranked
22 citations

Thomas B. Davis, Lance Pflieger, Michael Nebozhyn, Andrey Loboda, Heiman Wang +5 more

Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

Scientific Reports(2021)10.1038/s41598-021-91934-5
N/A
0DataRank · unranked
14 citations

Kajsa E. Affolter, Angela K. Snow, Karen Curtin, Austin R. Cannon, Lisa Cannon‐Albright +3 more